Reminder: Cardlytics Investors Facing Pending Class Action Lawsuit
Investors who have invested in Cardlytics are being reminded by Levi & Korsinsky about the ongoing class action lawsuit with a deadline for lead plaintiff designation set for March 25, 2025. This lawsuit was filed in the United States District Court for the Northern District of Georgia on behalf of investors who purchased Cardlytics securities between November 1, 2019, and December 15, 2020.
The lawsuit alleges that Cardlytics made false and misleading statements regarding its business, operations, and prospects. Specifically, it is claimed that the company failed to disclose important information about its major client and the extent to which that client relied on several key customers. The lawsuit further alleges that Cardlytics lacked adequate internal controls over financial reporting and failed to disclose material weaknesses in its internal control over financial reporting.
As a result of these alleged misrepresentations and omissions, Cardlytics stock prices were artificially inflated during the class period. When the truth about the company’s business practices was revealed, its stock prices dropped significantly, causing financial harm to investors who had purchased Cardlytics securities at inflated prices.
Investors who wish to serve as lead plaintiff in the class action lawsuit must file a motion with the court by March 25, 2025. It is important for investors who purchased Cardlytics securities during the specified class period to consider their legal options and the potential consequences of the lawsuit on their investments.
Levi & Korsinsky is a nationally recognized law firm with significant experience in securities litigation and class action lawsuits. The firm represents investors who have been defrauded by companies that engage in deceptive business practices and provides aggressive representation to protect the rights of investors.
Investors are encouraged to contact Levi & Korsinsky if they have any questions about the class action lawsuit against Cardlytics or if they wish to learn more about their legal rights and options. The firm offers a free consultation to investors to discuss their potential claims and determine the best course of action for their specific situation.
With the lead plaintiff deadline for the class action lawsuit against Cardlytics approaching, investors should act promptly to protect their rights and seek potential recovery for any financial losses they may have suffered as a result of the alleged securities fraud. Levi & Korsinsky is committed to holding companies accountable for their deceptive practices and helping investors seek justice for their losses. Investors who have been impacted by the alleged misconduct of Cardlytics are encouraged to reach out to Levi & Korsinsky for a confidential and no-obligation consultation.
